Study co-led by the Institute for Systems Biology (ISB) maps how rare mixed tumors evolve…
Approximately 20% of patients with immune thrombocytopenia previously had minimal benefit from current therapies Results from a phase 2 clinical trial designed and overseen by researchers at Mass General Brigham Cancer Institute show that…
Investigational drug could reduce need for repeat surgeries after total knee replacement The University of…
New research suggests that certain genetic variants can decrease the ability of GLP-1 diabetes drugs to regulate blood sugar — a mysterious phenomenon known as GLP-1 resistance. More than a quarter of…
Though overall risk remains small, study led by cedars-sinai finds long-term use of antidepressants and…
Researchers report that anxiety about radiation worsened birth outcomes after the Fukushima nuclear accident Fetal development is a critical stage with effects that can last throughout life. Yet, identifying the effects of…
Gluten transfer is possible, but the risk is low and easily reduced For people living with…
The latest findings from the Global Brain Health Institute (GBHI) at Trinity College Dublin identify important…
Fragments of tumour DNA circulating in the bloodstream of patients with breast cancer can predict…
INSIGHTS
